Alex Thompson
Stock Analyst at Stifel
(0)
# 3576
Out of 3,975 analysts
39
Total ratings
37.50%
Success rate
-17.87%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ascendis Pharma | Maintains: Strong Buy | 200 207 | 139.98 | 47.88% | 2 | Nov 15, 2024 | |
Oruka Therapeutics | Initiates Coverage On: Buy | 49 | n/a | n/a | 1 | Oct 11, 2024 | |
Morphic Holding | Maintains: Hold | 30 57 | n/a | n/a | 4 | Jul 22, 2024 | |
argenx | Maintains: Strong Buy | 485 500 | 621.4 | -19.54% | 4 | Jun 24, 2024 | |
Third Harmonic Bio | Initiates Coverage On: Buy | 23 | 11.13 | 106.65% | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 36 54 | 24.25 | 122.68% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 44 | 25.32 | 73.78% | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 6 2 | 2.53 | -20.95% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 8 10 | 18.99 | -47.34% | 2 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 66 69 | 53.37 | 29.29% | 2 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 2 1 | 2.65 | -62.26% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 | 20.12 | 98.81% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 1.66 | 2309.64% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 34 | 24.87 | 36.71% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 43 41 | n/a | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33 | 13.55 | 143.54% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 37 | n/a | n/a | 1 | Sep 7, 2022 |